GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sattva Sukun Lifecare Ltd

Sattva Sukun Lifecare approves Q1 FY27 un-audited results, reviews rights issue fund use

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Aug 2026, 04:04 PM IST  ·  BSE ID: cc916317-3959-4ca8-9fa9-21ec8c299fa3
View Original BSE Filing (PDF)
💡
In Simple Terms
The company board reviewed its latest financial report and confirmed funds from a past share offering were used as planned.
🤖 AI Summary
  • Sattva Sukun Lifecare approved Q1 FY27 un-audited financial results on August 4, 2026.
  • The company reviewed the use of proceeds from its Rights Issue dated July 7, 2025.
  • Limited review report on Q1 FY27 results was taken on record.
  • No deviation was found in the utilisation of rights issue funds.
  • The Board meeting commenced at 03:15 PM and concluded at 03:45 PM.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Amount Raised (Rights Issue)
Rs./- 191601248.00
Quarter ended
30-06-2026
Original Allocation (Working Capital)
470.00 Lakhs
Utilized Funds (Working Capital)
220.00 Lakhs
Original Allocation (Business Expansion)
500.00 Lakhs
Utilized Funds (Business Expansion)
300.00 Lakhs
Original Allocation (Subsidiary Investment)
3500.00 Lakhs
Utilized Funds (Subsidiary Investment)
1194.16 Lakhs
Original Allocation (General Corporate Purposes)
400.00 Lakhs
Utilized Funds (General Corporate Purposes)
116.16 Lakhs
Original Allocation (Issue Related Expenses)
80.00 Lakhs
Utilized Funds (Issue Related Expenses)
61.49 Lakhs
Total Funds Raised
191601248.00
Total Funds Utilized
1891.81 Lakhs
🏢 How This Affects the Company
📈
Business Impact
Approval of financial results provides transparency on business performance. Review of fund utilization confirms adherence to previous capital raising plans.
💰
Financial Impact
The approved un-audited results provide a snapshot of the company's financial health for Q1 FY27. Confirmation of no deviation in fund use alleviates concerns about financial stewardship.
⚠️
Risk Impact
Confirmation of no deviation in fund use reduces financial risk related to misallocation of capital raised.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this board meeting outcome.
👤
Who Is Affected
All shareholders are affected by the transparency of financial results and confirmation of proper fund utilization.
🔍
Management Signal
This signals management's adherence to regulatory disclosures and responsible stewardship of raised capital.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q2 FY27 un-audited financial results disclosure.
Further updates on business expansion plans.
Management commentary on Q1 FY27 performance.
LOW RISK Routine financial results disclosure and confirmation of fund utilization.
💡 Investor Takeaway
Sattva Sukun Lifecare's board approved Q1 FY27 un-audited results and confirmed no deviation in the use of Rs. 19,16,01,248.00 raised via rights issue.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmation of no deviation in the utilisation of Rs. 19,16,01,248.00 raised via rights issue.
  • Board approved un-audited financial results and limited review report for Q1 ended June 30, 2026.
❓ Frequently Asked Questions
What did Sattva Sukun Lifecare's Board of Directors approve?
The Board approved the un-audited financial results for the first quarter ended June 30, 2026, and the limited review report.
Did Sattva Sukun Lifecare deviate from its rights issue fund utilization plan?
No, the company reviewed the use of proceeds from its Rights Issue dated July 7, 2025, and confirmed there was no deviation.
How much was raised via Sattva Sukun Lifecare's Rights Issue?
The company raised Rs./- 191601248.00 through its Rights Issue conducted on July 7, 2025.
What were the total utilized funds from the Rights Issue by June 30, 2026?
Total utilized funds from the Rights Issue as of June 30, 2026, amounted to 1891.81 Lakhs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.